Original Article: Atopic Dermatitis, Urticaria and Skin Disease

69 Articles

Skin biomarkers predict development of atopic dermatitis in infancy

Rinnov, M.R., Halling, A.-S., Gerner, T., et al. Allergy. First published: 16 September 2022

Early initiation of short-term emollient use for the prevention of atopic dermatitis in high risk infants – the STOP AD randomised controlled trial

Chaoimh, C.N., Lad, D., Nico, C., et al. Allergy. First published: 23 August 2022

Molecular networks in atopic mothers impact the risk of infant atopy

Schedel, M., Leach, S.M., Strand, M.J., et al. Allergy. First published: 22 August 2022

Single-cell profiles reveal distinctive immune response in atopic dermatitis in contrast to psoriasis

Zhang, B., Roesner, L.M., Traidl, S., et al. Allergy. First published: 20 August 2022

The abundance of Ruminococcus bromii is associated with faecal butyrate levels and atopic dermatitis in infancy

Sasaki, M., Schwab, C., Ramirez Garcia, A., et al. Allergy. First published: 02 August 2022

Tonsillar transcriptional profiles in atopic and non-atopic subjects

Hanif, T., Ivaska, L.E., Ahmad, F., et al. Allergy. First published: 28 July 2022

Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis

Spekhorst, L.S., Bakker, D., Drylewicz, J., et al. Allergy. First published: 15 July 2022

Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis

Berdyshev, E., Goleva, E., Bissonnette, R., et al. Allergy. First published: 11 July 2022

Development of the cold urticaria activity score

Ahsan, D. M., Altrichter, S., Gutsche, A., et al. Allergy. First published: 11 April 2022

Circadian rhythm affects the magnitude of contact hypersensitivity response in mice

Miyake, T., Egawa, G., Chow, Z., et al. Allergy. First published: 15 April 2022

Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization

Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022

Risk factors for systemic reactions in typical cold urticaria: results from the COLD-CE study

Bizjak, M., Košnik, M., Dinevski, D., et al. Allergy. First published: 04 December 2021

Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study

Maurer, M, Giménez-Arnau, A, Bernstein, JA, et al. Allergy. First published: 13 November 2021

Heterogeneous origin of IgE in atopic dermatitis and psoriasis revealed by B cell receptor repertoire analysis

Luo, L, Luo, Y, Xu, J, et al. Allergy. First published: 05 November 2021

Impaired skin barrier and allergic sensitization in early infancy

Wärnberg Gerdin, S, Lie, A, Asarnoj, A, et al. Allergy. First published: 05 November 2021

Assessment of biomarkers in pediatric atopic dermatitis by tape strips and skin biopsies

Andersson, A.M., Sølberg, J., Koch, A., et al. Allergy. First published: 25 October 2021

Transcriptome-based identification of novel endotypes in adult atopic dermatitis

Lefèvre-Utile, A., Saichi, M., Oláh, P., et al. Allergy. First published: 24 October 2021

The benefit of late readings in patch testing depends both on allergen and patient characteristics

Forkel, S., Schubert, S., Dickel, H., et al. Allergy. First published: 23 October 2021

Specific T cells targeting Staphylococcus aureus Fibronectin-binding protein 1 induce a type 2/type 1 inflammatory response in sensitized atopic dermatitis patients

Farag, A.K., Roesner, L.M., Wieschowski, S., et al. Allergy. First published: 03 October 2021

Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation

Kim, J-M, Im, YN, Chung, Y-J, et al. Allergy. First published: 03 October 2021

Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients

Guttman-Yassky, E, Renert-Yuval, Y, Bares, J, et al. Allergy. First published: 30 August 2021

Increasing severity of early-onset atopic dermatitis, but not late-onset, associates with development of aeroallergen sensitization and allergic rhinitis in childhood

Schoos, A-MM, Chawes, BL, Bønnelykke, K, Stokholm, J, Rasmussen, MA, Bisgaard, H. Allergy. First published: 24 September 2021

Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedema

Bindke, G., Gehring, M., Wieczorek, D., Kapp, A., Buhl, T. and Wedi, B. Allergy. First published: 20 July 2021

Long-term prevention of hereditary angioedema attacks with lanadelumab: the HELP OLE Study

Banerji, A., Bernstein, J.A., Johnston, D.T., et al. Allergy. First published: 21 July 2021

Environment-dependent alterations of immune mediators in urban and rural south African children with atopic dermatitis

Lunjani, N, Tan, G, Dreher, A, et al. Allergy. 2022; 77: 569– 581

MR1-dependent immune surveillance of the skin contributes to pathogenesis and is a photobiological target of UV light therapy in a mouse model of atopic dermatitis.

Naidoo, K., Woods, K., Pellefigues, C., et al. Allergy. 2021; 76: 3155-3170

Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis

Kopfnagel, V., Dreyer, S., Zeitvogel, J., et al. Allergy. 2021; 76: 3145-3154

Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE study

Kocatürk, E, Al-Ahmad, M, Krause, K, et al. Allergy. 2021; 76: 3133-3144

Prenatal paraben exposure and atopic dermatitis-related outcomes among children

Thürmann, L., Herberth, G., Seiwert, B., et al. Allergy. 2021; 76: 3122-3132

Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 response

Villani, A.P., Pavel, A.B., Wu, J., et al. Allergy. 2021; 76: 3107-3121

Direct assessment of individual skin barrier components by electrical impedance spectroscopy

Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106

High-dimensional analysis defines multicytokine T-cell subsets and supports a role for IL-21 in atopic dermatitis

Czarnowicki, T., Kim, H.J., Villani, et al. Allergy. 2021; 76: 3080-3093

Electrical impedance spectroscopy for the characterization of skin barrier in atopic dermatitis

Rinaldi, A.O., Korsfeldt, A., Ward, S. et al. Allergy. 2021; 76: 3066-3079

An integrated scalp and blood biomarker approach suggeststhe systemic nature of alopecia areata

Glickman, J.W., Dubin, C., Dahabreh, D., et al. Allergy. 2021; 76: 3053-3065

Impact of anxiety, stress and depression related to COVID-19 pandemic on the course of hereditary angioedema with C1 inhibitor deficiency

Eyice Karabacak, D., Demir, S., Yeğit, O.O., et al. Allergy.2021; 76: 2535-2543

Association between ambient air pollution and development and persistence of atopic and non-atopic eczema in a cohort of adults

Lopez, D.J., Lodge, C.J., Bui, D.S., et al. Allergy.2021; 76: 2524-2534

Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum

Bin, L., Malley, C., Taylor, P., et al. Allergy.2021; 76: 2510-2523

Skewed inflammation is associated with aberrant interleukin-37 signaling pathway in atopic dermatitis

Hou, T., Tsang, M.S.-M., Chu, et al. Allergy.2021; 76: 2102-2114

Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry

Chiricozzi, A., Talamonti, M., De Simone, C., et al. Allergy. 2021; 76: 1813-1824

Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial

Ohsawa, I., Honda, D., Suzuki, Y., Allergy.2021; 76: 1789-1799

https://onlinelibrary.wiley.com/doi/10.1111/all.14692

Fatty acid-binding protein 3 controls contact hypersensitivity through regulating skin dermal Vγ4+ γ/δ T cell in a murine model

Kobayashi, S, Phung, HT, Kagawa, Y, et al. et al. Allergy. 2021; 76: 1776.1788

Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study

Lumry, W.R., Weller, K., Magerl, M., et al. Allergy.2021; 76: 1188-1198

Microbial and transcriptional differences elucidate atopic dermatitis heterogeneity across skin sites

Ottman, N, Barrientos-Somarribas, M, Fyhrquist, N, et al. Allergy. 2021; 76: 1173– 1187

Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins

Lauffer, F, Baghin, V, Standl, M, et al. Allergy. 2021; 76: 1158– 1172

The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

Kocatürk, E, Salman, A, Cherrez-Ojeda, I, et al. Allergy. 2021; 76: 816– 830

Integrative transcriptome analysis deciphers mechanisms of nickel contact dermatitis

Wisgrill, L, Werner, P, Jalonen, E, et al. Allergy. 2021; 76: 804– 815

Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin

Pavel A. B., Renert- Yuval, Y., Wu, J., et al. Allergy. 2021; 76: 314- 325

Biofilm propensity of Staphylococcus aureus skin isolates is associated with increased atopic dermatitis severity and barrier dysfunction in the MPAACH pediatric cohort

Gonzalez T., Stevens, M. L., Baatyrbek Kyzy, A., et al. Allergy. 2021; 76:302- 313

Inhibition of mite-induced dermatitis, pruritus, and nerve sprouting in mice by the endothelin receptor antagonist bosentan

Kido-Nakahara M., Wang, B., Ohno, F., et al. Allergy. 2021; 76: 291- 301

Dysregulated skin barrier function in Tmem79 mutant mice promotes IL-17A-dependent spontaneous skin and lung inflammation

Saunders, SP, Floudas, A, Moran, T, et al. Allergy. 2020; 75: 3216– 3227

IgM and IgA in addition to IgG autoantibodies against FcɛRIα are frequent and associated with disease markers of chronic spontaneous urticaria

Altrichter, S, Zampeli, V, Ellrich, A, Zhang, K, Church, MK, Maurer, M. Allergy. 2020; 75: 3208– 3215

Skin pH–dependent Staphylococcus aureus abundance as predictor for increasing atopic dermatitis severity

Hülpüsch, C, Tremmel, K, Hammel, G, et al. Allergy. 2020; 75: 2888– 2898

Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks

Riedl, MA, Maurer, M, Bernstein, JA, et al. Allergy. 2020; 75: 2879– 2887

Skin-infiltrating basophils promote atopic dermatitis-like inflammation via IL-4 production in mice

Yamanishi, Y, Mogi, K, Takahashi, K, Miyake, K, Yoshikawa, S, Karasuyama, H. Allergy. 2020; 75: 2613– 2622

Comel-Netherton syndrome: A local skin barrier defect in the absence of an underlying systemic immunodeficiency

Stuvel, K, Heeringa, JJ, Dalm, VASH, et al. Allergy. 2020; 75: 1710– 1720

Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor

Bova, M, Suffritti, C, Bafunno, V, et al. Allergy. 2020; 75: 1394– 1403

Development of the angioedema control test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema

Weller, K, Donoso, T, Magerl, M, et al. Allergy. 2020; 75: 1165– 1177

Interleukin 31 in insect bite hypersensitivity-Alleviating clinical symptoms by active vaccination against itch

Olomski, F, Fettelschoss, V, Jonsdottir, S, et al. Allergy. 2020; 75: 862– 871

Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis

Fricke, J, Ávila, G, Keller, T, et al. Allergy. 2020; 75: 423– 432

Exonic mutations associated with atopic dermatitis disrupt lympho-epithelial kazal-type related inhibitor action and enhance its degradation

Ramesh, K, Matta, SA, Chew, FT, Mok, YK. Allergy. 2020; 75: 403– 411

Postnatal probiotics and allergic disease in very preterm infants: Sub-study to the ProPrems randomized trial

Plummer, EL, Chebar Lozinsky, A, Tobin, JM, et al. Allergy. 2020; 75: 127– 136

Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

Ariëns, LFM, van der Schaft, J, Bakker, DS, et al. Allergy. 2020; 75: 116– 126

Markers of microbial exposure lower the incidence of atopic dermatitis

Chatenoud, L, Bertuccio, P, Turati, F, et al. Allergy. 2020; 75: 104– 115

Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study

Schoepke, N, Asero, R, Ellrich, A, et al. Allergy. 2019; 74: 2427– 2436

Direct assessment of skin epithelial barrier by electrical impedance spectroscopy

Rinaldi, AO, Morita, H, Wawrzyniak, P, et al. Allergy. 2019; 74: 1934– 1944

Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β

Schwartz, C, Moran, T, Saunders, SP, et al. Allergy. 2019; 74: 1920– 1933

Langerhans cells mediate the skin-induced tolerance to ovalbumin via Langerin in a murine model

Luo, Y, Wang, S, Liu, X, Wen, H, Li, W, Yao, X. Allergy. 2019; 74: 1738– 1747

Pruritus in ordinary scabies: IL-31 from macrophages induced by overexpression of thymic stromal lymphopoietin and periostin

Hashimoto, T, Satoh, T, Yokozeki, H. Allergy. 2019; 74: 1727– 1737

Transient epidermal barrier deficiency and lowered allergic threshold in filaggrin‐hornerin (FlgHrnr−/−) double‐deficient mice

Rahrig, S, Dettmann, JM, Brauns, B, et al. Allergy. 2019; 74: 1327– 1339

Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti-inflammatory drug-induced urticaria

Doña, I, Jurado-Escobar, R, Perkins, JR, et al. Allergy. 2019; 74: 1135– 1144